Century Therapeutics Inc. (IPSC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Century Therapeutics Inc.

    NASDAQ: IPSC · Real-Time Price · USD
    0.56
    0.05 (9.10%)
    At close: Oct 06, 2025, 3:59 PM
    0.56
    0.83%
    After-hours: Oct 06, 2025, 07:13 PM EDT

    Century Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.59M 2.23M 5.2M n/a
    Cost of Revenue
    		 n/a n/a 10.07M 4.58M
    Gross Profit
    		 6.59M 2.23M -4.87M -4.58M
    Operating Income
    		 -138.14M -146.55M -133.83M -94.88M
    Interest Income
    		 13.01M 12.68M 2.99M 898K
    Pretax Income
    		 -124.78M -134.79M -130.84M -95.78M
    Net Income
    		 -126.57M -136.67M -130.93M -95.82M
    Selling & General & Admin
    		 33.16M 34.71M 31.86M 19.23M
    Research & Development
    		 107.24M 92.71M 107.17M 75.65M
    Other Expenses
    		 4.33M 21.36M 4.42M 377K
    Operating Expenses
    		 144.73M 148.78M 139.03M 94.88M
    Interest Expense
    		 n/a 540K 1.1M 1.27M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 144.73M 148.78M 139.03M 94.88M
    Income Tax Expense
    		 1.79M 1.88M 91K 43K
    Shares Outstanding (Basic)
    		 78.65M 59.31M 57.76M 55.01M
    Shares Outstanding (Diluted)
    		 78.65M 59.31M 57.76M 55.01M
    EPS (Basic)
    		 -1.61 -2.3 -2.27 -1.74
    EPS (Diluted)
    		 -1.61 -2.3 -2.27 -1.74
    EBITDA
    		 -111.47M -121.21M -119.34M -89.92M
    EBIT
    		 -124.78M -134.25M -129.64M -94.51M
    Depreciation & Amortization
    		 13.3M 13.04M 10.07M 4.58M

    Add to Watchlist